Skip to main content

and
  1. No Access

    Chapter

    Novel Drugs for Diabetes Therapy

    Since the first use of insulin 100 years ago, there have been marked improvements in diabetes therapy including, but not limited to, the development of oral antidiabetic agents (OADs), incretin mimetics and in...

    Tim Heise in From Obesity to Diabetes (2022)

  2. Article

    Open Access

    Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter]

    Othmar Moser, Michael C. Riddell, Max L. Eckstein, Peter Adolfsson in Diabetologia (2021)

  3. Article

    Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)

    Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, ...

    Othmar Moser, Michael C. Riddell, Max L. Eckstein, Peter Adolfsson in Diabetologia (2020)

  4. Article

    Bed rest and resistive vibration exercise unveil novel links between skeletal muscle mitochondrial function and insulin resistance

    Physical inactivity has broad implications for human disease including insulin resistance, sarcopenia and obesity. The present study tested the hypothesis that (1) impaired mitochondrial respiration is linked ...

    Helena C. Kenny, Floriane Rudwill, Laura Breen, Michele Salanova in Diabetologia (2017)

  5. Article

    Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes

    Sodium glucose co-transporter 2 (SGLT2) inhibitors lower glycaemia by inducing glycosuria, but raise endogenous glucose production (EGP). Metformin lowers glycaemia mainly by suppressing EGP. We compared the e...

    Elza Muscelli, Brenno Astiarraga, Elisabetta Barsotti, Andrea Mari in Diabetologia (2016)

  6. No Access

    Article

    Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment

    NMDA receptors in pancreatic beta cells inhibit glucose-stimulated insulin secretion, and inhibiting these receptors with an over-the-counter medication improves diabetes in mouse models

    Jan Marquard, Silke Otter, Alena Welters, Alin Stirban, Annelie Fischer in Nature Medicine (2015)

  7. Article

    35th Annual Meeting of the European Association for the Study of Diabetes

    A. Melander, J. Olsson, G. Lindberg, A. Salzman, T. Howard, P. Stang in Diabetologia (1999)